Opthea Limited Sponsored ADR (OPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

The Australian market has recently experienced a downturn, with the ASX200 down 0.6% at 8,280 points amid concerns over upcoming US jobs data and broader global economic uncertainties. In this ...

Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on ...

Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...

Hawkeye Bio selected HydroGraph's graphene for use in the company's biomedical sensor aimed at the early detection of lung ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in DME Published in peer-reviewed journal Translational ...

Other stars in December included Orthocell (ASX:OCC), which was up 67% amid “outstanding” clinical trial results and expected ...